JP2001520878A5 - - Google Patents

Info

Publication number

JP2001520878A5

JP2001520878A5 JP2000518058A JP2000518058A JP2001520878A5 JP 2001520878 A5 JP2001520878 A5 JP 2001520878A5 JP 2000518058 A JP2000518058 A JP 2000518058A JP 2000518058 A JP2000518058 A JP 2000518058A JP 2001520878 A5 JP2001520878 A5 JP 2001520878A5

Authority

JP

Japan

Prior art keywords

neural stem

pluripotent neural

stem cells

neurons

cells

Prior art date

1998-10-23

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 description 18
• 210000001178 neural stem cell Anatomy 0.000 description 17
• 210000002569 neuron Anatomy 0.000 description 15
• 210000004027 cell Anatomy 0.000 description 10
• 230000001939 inductive effect Effects 0.000 description 5
• 102000003951 Erythropoietin Human genes 0.000 description 4
• 108090000394 Erythropoietin Proteins 0.000 description 4
• 206010021143 Hypoxia Diseases 0.000 description 4
• 229940105423 erythropoietin Drugs 0.000 description 4
• 239000003102 growth factor Substances 0.000 description 4
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
• 238000004113 cell culture Methods 0.000 description 3
• 230000004069 differentiation Effects 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000003814 drug Substances 0.000 description 3
• 230000007954 hypoxia Effects 0.000 description 3
• 230000001537 neural effect Effects 0.000 description 3
• 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
• 101800003838 Epidermal growth factor Proteins 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 230000000694 effects Effects 0.000 description 2
• 229940116977 epidermal growth factor Drugs 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical group C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 2
• 208000029028 brain injury Diseases 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 230000004770 neurodegeneration Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 238000012216 screening Methods 0.000 description 1